SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL

被引:0
|
作者
Pagliaro, L. [1 ,2 ,3 ]
Dalla Tor, L. Moron [1 ]
Monica, L. [1 ]
Andrei, P. [1 ]
Vento, F. [1 ]
Simoncini, E. [1 ]
Kleissle, Sabrina [4 ]
Neuenschwander, M. [5 ]
Gherli, A. [1 ]
Cerretani, E. [1 ]
D'Antuono, A. [1 ]
Montanaro, A. [1 ]
Roti, G. [1 ,2 ]
机构
[1] Univ Parma, Dipartimento Med & Chirurg, Lab Ematol Traslaz & Chemogen THEC, Parma, Italy
[2] Azienda Osped Univ Parma, Ematol, Parma, Italy
[3] Azienda Osped Univ Parma, CTMO, Parma, Italy
[4] Max Delbrueck Ctr Mol Med Helmholtz Assoc MDC, Berlin, Germany
[5] Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C02
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [1] Identifying Mechanisms of Glucocorticoid Resistance in Relapsed Pediatric T-ALL
    Roderick, Justine E.
    Gallagher, Kayleigh M.
    Tang, Katherine M.
    Kugler-Umana, Olivia
    Zhu, Lihua J.
    Green, Michael R.
    Kelliher, Michelle
    BLOOD, 2016, 128 (22)
  • [2] Pharmacological Inhibition of Lck is Able to Revert Glucocorticoid Resistance in Pediatric T-ALL
    Serafin, Valentina
    Capuzzo, Giorgia
    Milani, Gloria
    Bresolin, Silvia
    Pinazza, Marica
    Minuzzo, Sonia
    Indraccolo, Stefano
    Bortolozzi, Roberta
    Basso, Giuseppe
    Accordi, Benedetta
    BLOOD, 2016, 128 (22)
  • [3] Inhibition of NOTCH1 signaling reverses glucocorticoid resistance in T-ALL
    Real, Pedro J.
    Tosello, Valeria
    Ai, Walden
    Palomero, Teresa
    Sulis, Maria Luisa
    Castillo, Mireia
    Homminga, Irene
    Meijerink, Jules
    Cordon-Cardo, Carlos
    Ferrando, Adolfo
    BLOOD, 2007, 110 (11) : 52A - 52A
  • [4] Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance
    Olivas-Aguirre, Miguel
    Perez-Chavez, Jesus
    Torres-Lopez, Liliana
    Hernandez-Cruz, Arturo
    Pottosin, Igor
    Dobrovinskaya, Oxana
    CANCERS, 2023, 15 (02)
  • [5] Inhibition of NOTCH1 Signaling and Glucocorticoid Therapy in T-ALL
    Real, Pedro Jose
    Tosello, Valeria
    Palomero, Teresa
    Castillo, Mireia
    Sawai, Catherine
    Sulis, Maria Luisa
    Meijerink, Jules P. P.
    Basso, Giuseppe
    Aifantis, Iannis
    Cordon-Cardo, Carlos
    Ferrando, Adolfo A.
    BLOOD, 2008, 112 (11) : 116 - 116
  • [6] A T-ALL order: a new risk classifier for T-ALL
    Newman, Haley
    Teachey, David T.
    BLOOD, 2024, 144 (15) : 1545 - 1547
  • [7] Oncogenic signaling pathways and resistance to therapy in T-ALL
    Ferrando, Adolfo
    CANCER RESEARCH, 2016, 76
  • [8] Late relapses of childhood T-ALL are frequently second T-ALL
    Szczepanski, Tomasz
    van der Velden, Vincent H. J.
    Van Vlierberghe, Pieter
    Gruhn, Berrid
    Panzer-Grumayer, Renate
    Spinelli, Monica
    Cave, Helene
    zur Stadt, Udo
    Campana, Dario
    Schrauder, Andre
    van Wering, Elisabeth
    Meijerink, Jules P. P.
    van Dongen, Jacques J. M.
    BLOOD, 2007, 110 (11) : 430A - 430A
  • [9] EFFECTS OF CICLOPIROX OLAMINE ON REVERSING GLUCOCORTICOID RESISTANTANCE IN T-ALL CELL LINES
    Ma, Z.
    Zhu, Y.
    Liu, H.
    Gao, J.
    Li, Q.
    Jia, C.
    Fu, R.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 57 - 58
  • [10] Detonating T-ALL
    Mamonkin, Maksim
    BLOOD, 2020, 136 (11) : 1218 - 1219